Furthermore, prospective studies should focus on fortifying phagocytic activity and aligning it with effector T-cell functions, with the ultimate goal of establishing a more nuanced understanding of the potential role of CD47 in osteosarcoma immunotherapy. The gene discussed is CD47; the disease is osteosarcoma.